Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05122182 |
|---|---|
| Brief Title: | Controlled Trial of Angiotensin Receptor Blocker (ARB) & Chemokine Receptor Type 2 (CCR2) Antagonist for the Treatment of COVID-19 (CLARITY 2) |
| First Submitted : | November 14, 2021 |
| First Submitted that Met QC Criteria : | November 14, 2021 |
| First Posted : | November 16, 2021 |
| Last Update Submitted that Met QC Criteria : | March 13, 2022 |
| Last Update Posted : | March 29, 2022 |